Lisata Therapeutics, Inc. (LSTA) income statement
LSTANasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.90−0.01 (-1.22%)
Close on Nov 20, 2026Market cap $8.10MP/E –Yield –
Lisata Therapeutics, Inc. financial ratios
See a number that looks wrong?